{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Herbal medicine", "inflammatory bowel disease", "medicinal plants", "phytotherapy"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31160909", "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "05", "Day": "22"}], "Language": ["eng"], "ELocationID": ["42", "10.4103/jrms.JRMS_590_17"], "Journal": {"ISSN": "1735-1995", "JournalIssue": {"Volume": "24", "PubDate": {"Year": "2019"}}, "Title": "Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences", "ISOAbbreviation": "J Res Med Sci"}, "ArticleTitle": "Phytotherapies in inflammatory bowel disease.", "Pagination": {"StartPage": "42", "MedlinePgn": "42"}, "Abstract": {"AbstractText": ["Inflammatory bowel disease (IBD) has been considered as a group of heterogeneous intestinal diseases that affects multiple organs outside of the gastrointestinal tract and is due to an uncontrolled inflammatory response mediated by the immune system. The IBD etiology has not been clearly defined, and it is considered as a multifactorial disease. Due to side effects of some conventional therapies, the consumption of complementary and alternative medicines, and in particular, the herbal therapy, more than before is increasing. Herbal therapy results for management of IBD by various mechanisms including leukotriene B4 inhibition, antioxidant activity, immune system regulation of nuclear factor-kappa B, as well as antiplatelet activity are favorable, and no unfortunate events have been yet reported. In this article, we aimed to review and report the herbal therapies established for management of human IBD or evaluated by animal IBD models. Their possible mechanisms of actions are also discussed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran."}], "LastName": "Ganji-Arjenaki", "ForeName": "Mahboube", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran."}], "LastName": "Rafieian-Kopaei", "ForeName": "Mahmoud", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "India", "MedlineTA": "J Res Med Sci", "NlmUniqueID": "101235599", "ISSNLinking": "1735-1995"}, "CoiStatement": "There are no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "de Mattos BR, Garcia MP, Nogueira JB, Paiatto LN, Albuquerque CG, Souza CL, et al. Inflammatory bowel disease: An overview of immune mechanisms and biological treatments. Mediators Inflamm. 2015;2015:493012.", "ArticleIdList": ["PMC4539174", "26339135"]}, {"Citation": "Mizoguchi A, Takeuchi T, Himuro H, Okada T, Mizoguchi E. Genetically engineered mouse models for studying inflammatory bowel disease. J Pathol. 2016;238:205\u201319.", "ArticleIdList": ["PMC4689626", "26387641"]}, {"Citation": "Stepaniuk P, Bernstein CN, Targownik LE, Singh H. Characterization of inflammatory bowel disease in elderly patients: A review of epidemiology, current practices and outcomes of current management strategies. Can J Gastroenterol Hepatol. 2015;29:327\u201333.", "ArticleIdList": ["PMC4578457", "26069892"]}, {"Citation": "Dong J, Chen Y, Tang Y, Xu F, Yu C, Li Y, et al. Body mass index is associated with inflammatory bowel disease: A systematic review and meta-analysis. PLoS One. 2015;10:e0144872.", "ArticleIdList": ["PMC4684381", "26658675"]}, {"Citation": "Ribaldone DG, Fagoonee S, Astegiano M, De Angelis C, Smedile A, Caviglia GP, et al. Coxib's safety in patients with inflammatory bowel diseases: A meta-analysis. Pain Physician. 2015;18:599\u2013607.", "ArticleIdList": ["26606012"]}, {"Citation": "Kozuch PL, Hanauer SB. Treatment of inflammatory bowel disease: A review of medical therapy. World J Gastroenterol. 2008;14:354\u201377.", "ArticleIdList": ["PMC2679125", "18200659"]}, {"Citation": "Atreya R, Neumann H, Neurath MF. Update: Chronic inflammatory bowel disease. Dtsch Med Wochenschr. 2015;140:1762\u201372.", "ArticleIdList": ["26583823"]}, {"Citation": "Brown SR, Coviello LC. Extraintestinal manifestations associated with inflammatory bowel disease. Surg Clin North Am. 2015;95:1245\u201359, vii.", "ArticleIdList": ["26596925"]}, {"Citation": "Vanhove W, Nys K, Vermeire S. Therapeutic innovations in inflammatory bowel diseases. Clin Pharmacol Ther. 2016;99:49\u201358.", "ArticleIdList": ["26509246"]}, {"Citation": "Hilsden RJ, Verhoef MJ, Rasmussen H, Porcino A, DeBruyn JC. Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:655\u201362.", "ArticleIdList": ["20848543"]}, {"Citation": "Hung A, Kang N, Bollom A, Wolf JL, Lembo A. Complementary and alternative medicine use is prevalent among patients with gastrointestinal diseases. Dig Dis Sci. 2015;60:1883\u20138.", "ArticleIdList": ["25556585"]}, {"Citation": "Nasri H, Shirzad H. Toxicity and safety of medicinal plants. J Herbmed Plarmacol. 2013;2:21\u20132."}, {"Citation": "Papakostas GI. Tolerability of modern antidepressants. J Clin Psychiatry. 2008;69(Suppl E1):8\u201313.", "ArticleIdList": ["18494538"]}, {"Citation": "Panossian A, Seo EJ, Wikman G, Efferth T. Synergy assessment of fixed combinations of herba andrographidis and radix eleutherococci extracts by transcriptome-wide microarray profiling. Phytomedicine. 2015;22:981\u201392.", "ArticleIdList": ["26407940"]}, {"Citation": "Malik TA. Inflammatory bowel disease: Historical perspective, epidemiology, and risk factors. Surg Clin North Am. 2015;95:1105\u201322, v.", "ArticleIdList": ["26596917"]}, {"Citation": "Danese S, Grisham M, Hodge J, Telliez JB. JAK inhibition using tofacitinib for inflammatory bowel disease treatment: A hub for multiple inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol. 2016;310:G155\u201362.", "ArticleIdList": ["PMC4971816", "26608188"]}, {"Citation": "de Souza HS, Fiocchi C. Immunopathogenesis of IBD: Current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13:13\u201327.", "ArticleIdList": ["26627550"]}, {"Citation": "Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119\u201324.", "ArticleIdList": ["PMC3491803", "23128233"]}, {"Citation": "Muro M, L\u00f3pez-Hern\u00e1ndez R, Mrowiec A. Immunogenetic biomarkers in inflammatory bowel diseases: Role of the IBD3 region. World J Gastroenterol. 2014;20:15037\u201348.", "ArticleIdList": ["PMC4223237", "25386052"]}, {"Citation": "Gersemann M, Wehkamp J, Stange EF. Innate immune dysfunction in inflammatory bowel disease. J Intern Med. 2012;271:421\u20138.", "ArticleIdList": ["22324936"]}, {"Citation": "Liu QL, Huang L, Zhao QJ, Li Q, He Z. Relationship between serum interleukin-17 level and inflammatory bowel disease. J Biol Regul Homeost Agents. 2016;30:181\u20138.", "ArticleIdList": ["27049090"]}, {"Citation": "Hlavaty T, Krajcovicova A, Letkovsky J, Sturdik I, Koller T, Toth J, et al. Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy. Bratisl Lek Listy. 2016;117:205\u201311.", "ArticleIdList": ["27075383"]}, {"Citation": "Zhang M, Deng CS, Zheng JJ, Xia J. Curcumin regulated shift from th1 to th2 in trinitrobenzene sulphonic acid-induced chronic colitis. Acta Pharmacol Sin. 2006;27:1071\u20137.", "ArticleIdList": ["16867261"]}, {"Citation": "Jiang H, Deng CS, Zhang M, Xia J. Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. World J Gastroenterol. 2006;12:3848\u201353.", "ArticleIdList": ["PMC4087932", "16804969"]}, {"Citation": "Deguchi Y, Andoh A, Inatomi O, Yagi Y, Bamba S, Araki Y, et al. Curcumin prevents the development of dextran sulfate sodium (DSS)-induced experimental colitis. Dig Dis Sci. 2007;52:2993\u20138.", "ArticleIdList": ["17429738"]}, {"Citation": "Camacho-Barquero L, Villegas I, S\u00e1nchez-Calvo JM, Talero E, S\u00e1nchez-Fidalgo S, Motilva V, et al. Curcumin, a curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol. 2007;7:333\u201342.", "ArticleIdList": ["17276891"]}, {"Citation": "Oh PS, Lim KT. Plant originated glycoprotein has anti-oxidative and anti-inflammatory effects on dextran sulfate sodium-induced colitis in mouse. J Biomed Sci. 2006;13:549\u201360.", "ArticleIdList": ["16586048"]}, {"Citation": "Ukil A, Maity S, Das PK. Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation. Br J Pharmacol. 2006;149:121\u201331.", "ArticleIdList": ["PMC1629406", "16880762"]}, {"Citation": "Maity S, Ukil A, Karmakar S, Datta N, Chaudhuri T, Vedasiromoni JR, et al. Thearubigin, the major polyphenol of black tea, ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. Eur J Pharmacol. 2003;470:103\u201312.", "ArticleIdList": ["12787838"]}, {"Citation": "Micallef MJ, Iwaki K, Ishihara T, Ushio S, Aga M, Kunikata T, et al. The natural plant product tryptanthrin ameliorates dextran sodium sulfate-induced colitis in mice. Int Immunopharmacol. 2002;2:565\u201378.", "ArticleIdList": ["11962735"]}, {"Citation": "Murakami A, Hayashi R, Tanaka T, Kwon KH, Ohigashi H, Safitri R, et al. Suppression of dextran sodium sulfate-induced colitis in mice by zerumbone, a subtropical ginger sesquiterpene, and nimesulide: Separately and in combination. Biochem Pharmacol. 2003;66:1253\u201361.", "ArticleIdList": ["14505804"]}, {"Citation": "Yousefi B, Jadidi-Niaragh F, Azizi G, Hajighasemi F, Mirshafiey A. The role of leukotrienes in immunopathogenesis of rheumatoid arthritis. Mod Rheumatol. 2014;24:225\u201335.", "ArticleIdList": ["24593197"]}, {"Citation": "Jupp J, Hillier K, Elliott DH, Fine DR, Bateman AC, Johnson PA, et al. Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:537\u201346.", "ArticleIdList": ["17230539"]}, {"Citation": "Chernyavsky AI, Galitovskiy V, Shchepotin IB, Grando SA. Anti-inflammatory effects of the nicotinergic peptides SLURP-1 and SLURP-2 on human intestinal epithelial cells and immunocytes. Biomed Res Int. 2014;2014:609086.", "ArticleIdList": ["PMC4024406", "24877120"]}, {"Citation": "Kirk KF, Nielsen HL, Thorlacius-Ussing O, Nielsen H. Optimized cultivation of campylobacter concisus from gut mucosal biopsies in inflammatory bowel disease. Gut Pathog. 2016;8:27.", "ArticleIdList": ["PMC4888738", "27252786"]}, {"Citation": "Vilahur G, Badimon L. Antiplatelet properties of natural products. Vascul Pharmacol. 2013;59:67\u201375.", "ArticleIdList": ["23994642"]}, {"Citation": "D'Ignazio L, Bandarra D, Rocha S. NF-\u03baB and HIF crosstalk in immune responses. FEBS J. 2016;283:413\u201324.", "ArticleIdList": ["PMC4864946", "26513405"]}, {"Citation": "Vlantis K, Wullaert A, Polykratis A, Kondylis V, Dannappel M, Schwarzer R, et al. NEMO prevents RIP kinase 1-mediated epithelial cell death and chronic intestinal inflammation by NF-\u03baB-dependent and -independent functions. Immunity. 2016;44:553\u201367.", "ArticleIdList": ["PMC4803910", "26982364"]}, {"Citation": "Baratchian M, Davis CA, Shimizu A, Escors D, Bagn\u00e9ris C, Barrett T, et al. Distinct activation mechanisms of NF-\u03baB regulator inhibitor of NF-\u03baB kinase (IKK) by isoforms of the cell death regulator cellular FLICE-like inhibitory protein (cFLIP) J Biol Chem. 2016;291:7608\u201320.", "ArticleIdList": ["PMC4817188", "26865630"]}, {"Citation": "Cheon JH, Kim JS, Kim JM, Kim N, Jung HC, Song IS, et al. Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking ikappaB kinase and ameliorates acute murine colitis. Inflamm Bowel Dis. 2006;12:1152\u201361.", "ArticleIdList": ["17119390"]}, {"Citation": "Zhang Y, Duan RD. Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells. Lipids Health Dis. 2009;8:51.", "ArticleIdList": ["PMC2789714", "19951413"]}, {"Citation": "Goel A, Ahmad FJ, Singh RM, Singh GN. 3-acetyl-11-keto-beta-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity. J Pharm Pharmacol. 2010;62:273\u20138.", "ArticleIdList": ["20487208"]}, {"Citation": "Mart\u00edn MC, Martinez A, Mendoza JL, Taxonera C, D\u00edaz-Rubio M, Fern\u00e1ndez-Arquero M, et al. Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility. Immunogenetics. 2007;59:833\u20137.", "ArticleIdList": ["17955236"]}, {"Citation": "Wan Saudi WS, Halim MA, Rudholm-Feldreich T, Gillberg L, Rosenqvist E, Tengholm A, et al. Neuropeptide S inhibits gastrointestinal motility and increases mucosal permeability through nitric oxide. Am J Physiol Gastrointest Liver Physiol. 2015;309:G625\u201334.", "ArticleIdList": ["26206857"]}, {"Citation": "Rezaie A, Khalaj S, Shabihkhani M, Nikfar S, Zamani MJ, Mohammadirad A, et al. Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients. Ann N Y Acad Sci. 2007;1095:305\u201314.", "ArticleIdList": ["17404043"]}, {"Citation": "Wang X, Zhao L, Han T, Chen S, Wang J. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-glucoside, an active component of Polygonum multiflorum thunb, on experimental colitis in mice. Eur J Pharmacol. 2008;578:339\u201348.", "ArticleIdList": ["17963744"]}, {"Citation": "Miao XP, Li JS, Ouyang Q, Hu RW, Zhang Y, Li HY, et al. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. Cochrane Database Syst Rev. 2014;(10):CD007744.", "ArticleIdList": ["25340915"]}, {"Citation": "El Miedany Y, Youssef S, Ahmed I, El Gaafary M. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. Am J Gastroenterol. 2006;101:311\u20137.", "ArticleIdList": ["16454836"]}, {"Citation": "Giannotta M, Tapete G, Emmi G, Silvestri E, Milla M. Thrombosis in inflammatory bowel diseases: What's the link? Thromb J. 2015;13:14.", "ArticleIdList": ["PMC4393581", "25866483"]}, {"Citation": "Voudoukis E, Karmiris K, Koutroubakis IE. Multipotent role of platelets in inflammatory bowel diseases: A clinical approach. World J Gastroenterol. 2014;20:3180\u201390.", "ArticleIdList": ["PMC3964390", "24696603"]}, {"Citation": "Pitchford SC. Novel uses for anti-platelet agents as anti-inflammatory drugs. Br J Pharmacol. 2007;152:987\u20131002.", "ArticleIdList": ["PMC2095110", "17603547"]}, {"Citation": "Kulnigg-Dabsch S, Schmid W, Howaldt S, Stein J, Mickisch O, Waldh\u00f6r T, et al. Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: The randomized, controlled thromboVIT trial. Inflamm Bowel Dis. 2013;19:1609\u201316.", "ArticleIdList": ["23644823"]}, {"Citation": "Langhorst J, Wulfert H, Lauche R, Klose P, Cramer H, Dobos GJ, et al. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. J Crohns Colitis. 2015;9:86\u2013106.", "ArticleIdList": ["25518050"]}, {"Citation": "Rahimi R, Mozaffari S, Abdollahi M. On the use of herbal medicines in management of inflammatory bowel diseases: A systematic review of animal and human studies. Dig Dis Sci. 2009;54:471\u201380.", "ArticleIdList": ["18618255"]}, {"Citation": "Park MY, Kwon HJ, Sung MK. Dietary aloin, aloesin, or aloe-gel exerts anti-inflammatory activity in a rat colitis model. Life Sci. 2011;88:486\u201392.", "ArticleIdList": ["21277867"]}, {"Citation": "Stenson WF. Role of eicosanoids as mediators of inflammation in inflammatory bowel disease. Scand J Gastroenterol Suppl. 1990;172:13\u20138.", "ArticleIdList": ["1972294"]}, {"Citation": "Kumar S, Singh BK, Pandey AK, Kumar A, Sharma SK, Raj HG, et al. Achromone analog inhibits TNF-alpha induced expression of cell adhesion molecules on human endothelial cells via blocking NF-kappaB activation. Bioorg Med Chem. 2007;15:2952\u201362.", "ArticleIdList": ["17321745"]}, {"Citation": "Omer B, Krebs S, Omer H, Noor TO. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: A double-blind placebo-controlled study. Phytomedicine. 2007;14:87\u201395.", "ArticleIdList": ["17240130"]}, {"Citation": "Altwegg R, Vincent T. TNF blocking therapies and immunomonitoring in patients with inflammatory bowel disease. Mediators Inflamm. 2014;2014:172821.", "ArticleIdList": ["PMC3976924", "24757282"]}, {"Citation": "Lee HG, Kim H, Oh WK, Yu KA, Choe YK, Ahn JS, et al. Tetramethoxy hydroxyflavone p7F downregulates inflammatory mediators via the inhibition of nuclear factor kappaB. Ann N Y Acad Sci. 2004;1030:555\u201368.", "ArticleIdList": ["15659838"]}, {"Citation": "Hatziieremia S, Gray AI, Ferro VA, Paul A, Plevin R. The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages. Br J Pharmacol. 2006;149:188\u201398.", "ArticleIdList": ["PMC2013802", "16894344"]}, {"Citation": "Denzler KL, Waters R, Jacobs BL, Rochon Y, Langland JO. Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals. PLoS One. 2010;5:e12561.", "ArticleIdList": ["PMC2933230", "20838436"]}, {"Citation": "Xia YF, Ye BQ, Li YD, Wang JG, He XJ, Lin X, et al. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol. 2004;173:4207\u201317.", "ArticleIdList": ["15356172"]}, {"Citation": "Levita J, Nawawi AA, Mutalib A, Ibrahim S. Andrographolide: A review of its anti-inflammatory activity via inhibition of NF-kappaB activation from computational chemistry aspects. Int J Pharmacol. 2010;6:569\u201376."}, {"Citation": "Chiou WF, Chen CF, Lin JJ. Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide. Br J Pharmacol. 2000;129:1553\u201360.", "ArticleIdList": ["PMC1571992", "10780958"]}, {"Citation": "Shen YC, Chen CF, Chiou WF. Andrographolide prevents oxygen radical production by human neutrophils: Possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol. 2002;135:399\u2013406.", "ArticleIdList": ["PMC1573154", "11815375"]}, {"Citation": "Burgos RA, Seguel K, Perez M, Meneses A, Ortega M, Guarda MI, et al. Andrographolide inhibits IFN-gamma and IL-2 cytokine production and protects against cell apoptosis. Planta Med. 2005;71:429\u201334.", "ArticleIdList": ["15931581"]}, {"Citation": "Iruretagoyena MI, Tobar JA, Gonz\u00e1lez PA, Sep\u00falveda SE, Figueroa CA, Burgos RA, et al. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. J Pharmacol Exp Ther. 2005;312:366\u201372.", "ArticleIdList": ["15331658"]}, {"Citation": "Liu J, Wang ZT, Ge BX. Andrograpanin, isolated from andrographis paniculata, exhibits anti-inflammatory property in lipopolysaccharide-induced macrophage cells through down-regulating the p38 MAPKs signaling pathways. Int Immunopharmacol. 2008;8:951\u20138.", "ArticleIdList": ["18486905"]}, {"Citation": "Tang T, Targan SR, Li ZS, Xu C, Byers VS, Sandborn WJ, et al. Randomised clinical trial: Herbal extract HMPL-004 in active ulcerative colitis \u2013 A double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther. 2011;33:194\u2013202.", "ArticleIdList": ["21114791"]}, {"Citation": "Recio MC, Andujar I, Rios JL. Anti-inflammatory agents from plants: Progress and potential. Curr Med Chem. 2012;19:2088\u2013103.", "ArticleIdList": ["22414101"]}, {"Citation": "Langmead L, Feakins RM, Goldthorpe S, Holt H, Tsironi E, De Silva A, et al. Randomized, double-blind, placebo-controlled trial of oral Aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther. 2004;19:739\u201347.", "ArticleIdList": ["15043514"]}, {"Citation": "Ben-Arye E, Goldin E, Wengrower D, Stamper A, Kohn R, Berry E, et al. Wheat grass juice in the treatment of active distal ulcerative colitis: A randomized double-blind placebo-controlled trial. Scand J Gastroenterol. 2002;37:444\u20139.", "ArticleIdList": ["11989836"]}, {"Citation": "Sandborn WJ, Targan SR, Byers VS, Rutty DA, Mu H, Zhang X, et al. Andrographis paniculata extract (HMPL-004) for active ulcerative colitis. Am J Gastroenterol. 2013;108:90\u20138.", "ArticleIdList": ["PMC3538174", "23044768"]}, {"Citation": "Rodr\u00edguez-Cabezas ME, G\u00e1lvez J, Camuesco D, Lorente MD, Concha A, Martinez-Augustin O, et al. Intestinal anti-inflammatory activity of dietary fiber (Plantago ovata seeds) in HLA-B27 transgenic rats. Clin Nutr. 2003;22:463\u201371.", "ArticleIdList": ["14512034"]}, {"Citation": "Gupta I, Parihar A, Malhotra P, Gupta S, L\u00fcdtke R, Safayhi H, et al. Effects of gum resin of boswellia serrata in patients with chronic colitis. Planta Med. 2001;67:391\u20135.", "ArticleIdList": ["11488449"]}, {"Citation": "Greenfield SM, Green AT, Teare JP, Jenkins AP, Punchard NA, Ainley CC, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther. 1993;7:159\u201366.", "ArticleIdList": ["8485269"]}, {"Citation": "Algieri F, Rodriguez-Nogales A, Rodriguez-Cabezas ME, Risco S, Ocete MA, Galvez J, et al. Botanical drugs as an emerging strategy in inflammatory bowel disease: A review. Mediators Inflamm. 2015;2015:179616.", "ArticleIdList": ["PMC4630406", "26576073"]}, {"Citation": "Stanke-Labesque F, Pofelski J, Moreau-Gaudry A, Bessard G, Bonaz B. Urinary leukotriene E4 excretion: A biomarker of inflammatory bowel disease activity. Inflamm Bowel Dis. 2008;14:769\u201374.", "ArticleIdList": ["18286646"]}, {"Citation": "Takada Y, Ichikawa H, Badmaev V, Aggarwal BB. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol. 2006;176:3127\u201340.", "ArticleIdList": ["16493072"]}, {"Citation": "Wang H, Syrovets T, Kess D, B\u00fcchele B, Hainzl H, Lunov O, et al. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis. J Immunol. 2009;183:4755\u201363.", "ArticleIdList": ["19752240"]}, {"Citation": "Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: Biological actions and medicinal applications. Curr Sci. 2004;87:44\u201353."}, {"Citation": "Ukil A, Maity S, Karmakar S, Datta N, Vedasiromoni JR, Das PK, et al. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br J Pharmacol. 2003;139:209\u201318.", "ArticleIdList": ["PMC1573841", "12770926"]}, {"Citation": "Larmonier CB, Uno JK, Lee KM, Karrasch T, Laubitz D, Thurston R, et al. Limited effects of dietary curcumin on th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection. Am J Physiol Gastrointest Liver Physiol. 2008;295:G1079\u201391.", "ArticleIdList": ["PMC2584828", "18818316"]}, {"Citation": "Epstein J, Docena G, MacDonald TT, Sanderson IR. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br J Nutr. 2010;103:824\u201332.", "ArticleIdList": ["19878610"]}, {"Citation": "Venkataranganna MV, Rafiq M, Gopumadhavan S, Peer G, Babu UV, Mitra SK, et al. NCB-02 (standardized curcumin preparation) protects dinitrochlorobenzene- induced colitis through down-regulation of NFkappa-B and iNOS. World J Gastroenterol. 2007;13:1103\u20137.", "ArticleIdList": ["PMC4146875", "17373747"]}, {"Citation": "Tao QS, Ren JA, Ji ZL, Li JS, Wang XB, Jiang XH, et al. Maintenance effect of polyglycosides of Tripterygium wilfordii on remission in postoperative Crohn disease. Zhonghua Wei Chang Wai Ke Za Zhi. 2009;12:491\u20133.", "ArticleIdList": ["19742342"]}, {"Citation": "Liao NS, Ren JA, Fan CG, Wang GF, Zhao YZ, Li JS, et al. Efficacy of polyglycosides of Tripterygium wilfordii in preventing postoperative recurrence of Crohn disease. Zhonghua Wei Chang Wai Ke Za Zhi. 2009;12:167\u20139.", "ArticleIdList": ["19296254"]}, {"Citation": "Rahimi R, Nikfar S, Abdollahi M. Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines: A meta-analysis. World J Gastroenterol. 2013;19:5738\u201349.", "ArticleIdList": ["PMC3769914", "24039370"]}, {"Citation": "Lal S, Prasad N, Ryan M, Tangri S, Silverberg MS, Gordon A, et al. Cannabis use amongst patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2011;23:891\u20136.", "ArticleIdList": ["21795981"]}, {"Citation": "Naftali T, Mechulam R, Lev LB, Konikoff FM. Cannabis for inflammatory bowel disease. Dig Dis. 2014;32:468\u201374.", "ArticleIdList": ["24969296"]}, {"Citation": "Imanzadeh F, Nasri P, Sadeghi S, Sayyari A, Dara N, Abdollah K, et al. Food allergy among Iranian children with inflammatory bowel disease: A preliminary report. J Res Med Sci. 2015;20:855\u20139.", "ArticleIdList": ["PMC4696370", "26759572"]}, {"Citation": "Tabatabaeian M, Afshar H, Roohafza HR, Daghaghzadeh H, Feizi A, Sharbafchi MR, et al. Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life. J Res Med Sci. 2015;20:577\u201384.", "ArticleIdList": ["PMC4621652", "26600833"]}, {"Citation": "Tabatabaeian M, Afshar H, Roohafza HR, Daghaghzadeh H, Feizi A, Sharbafchi MR, et al. Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life? J Res Med Sci. 2015;20:577\u201384. doi: 10.4103/1735-1995.165962.", "ArticleIdList": ["PMC4621652", "26600833"]}, {"Citation": "Minaiyan M, Mostaghel E, Mahzouni P. Preventive therapy of experimental colitis with selected iron chelators and anti-oxidants. Int J Prev Med. 2012;3:S162\u20139.", "ArticleIdList": ["PMC3399289", "22826760"]}]}], "History": [{"Year": "2017", "Month": "7", "Day": "21"}, {"Year": "2017", "Month": "7", "Day": "26"}, {"Year": "2019", "Month": "2", "Day": "25"}, {"Year": "2019", "Month": "6", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "5", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "5", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["31160909", "PMC6540767", "10.4103/jrms.JRMS_590_17", "JRMS-24-42"]}}]}